The effect of Rosa damascena on anxiety and sexual function in breastfeeding wome

Phase 1

Recruiting

• Conditions: Condition 1: anxiety. Condition 2: Sexual dysfunction.; Generalized anxiety disorder; Sexual dysfunction, not caused by organic disorder or disease; F41.1

• Registration Number: IRCT20211015052775N1
• Lead Sponsor: Ahvaz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 8 March 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 94

Inclusion Criteria

Breastfeeding
At least 6 weeks up to 12 months after delivery
Having a spouse
Primiparous
Single fetus
Basic Literacy
Scores less than 26 from the Sexual Function Questionnaire
Scores 20-53 from the Spielberger questionnaire

Exclusion Criteria

History of allergy to Rosa damascana and its derivatives
Specific disease of the breast and uterus
Taking certain medications that affect sexual function (such as antidepressants, aspirin, and anticoagulants)
Feeding the baby with formula
Smoking or alcohol consumption5
Pregnancy
A history of any mental illness or severe trauma in the last 6 months

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Score less than 26.5 in the Sexual Function Questionnaire (FSFI) and a score of 53-20 from the overt anxiety questionnaire and a score of 20-53 from the hidden anxiety section (STAI). Timepoint: 8 weeks. Method of measurement: The Sexual Function Questionnaire (FSFI) and the overt and covert anxiety questionnaire (STAI).